Pre-surgical CT Scan Assessment of Bone Mineral Density Before Resection of NHO of the Hip
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03914521|
Recruitment Status : Active, not recruiting
First Posted : April 16, 2019
Last Update Posted : June 5, 2020
Neurogenic heterotopic ossification (NHO) is defined as an ectopic ossification around proximal joints usually seen after traumatic brain injury, spinal cord injury or polytrauma.
NHO causes pain, partial or total joint ankylosis and vascular or nerve complications.
The osteopenia (low bone density) induced by ankylose increases the fracture risk of femoral neck during the hip surgery performed to remove the NHO.
The analyse of femoral head bone mineral density from hip pre-surgical CT scan could anticipate this kind of complication establishing a presurgical prognostic.
If as it turns out the bone density measured from hip pre-surgical CT scan is relevant fracture risk marker, a preventive osteosynthesis or femoral head and neck resection could be performed in the same time of NHO resection.
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||40 participants|
|Official Title:||Pre-surgical CT Scan Assessment of Femoral Head Bone Mineral Density Before Resection of Neurogenic Heterotopic Ossification (NHO) of the Hip|
|Actual Study Start Date :||March 1, 2019|
|Actual Primary Completion Date :||March 1, 2020|
|Estimated Study Completion Date :||September 1, 2020|
- femoral head bone mineral density [ Time Frame: 1 year ]femoral head bone mineral density
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03914521
|Montpellier, France, 34295|
|Principal Investigator:||Florence BAUMANN, MD||University Hospital, Montpellier|